EssilorLuxottica SA header image

EssilorLuxottica SA

EL

Equity

ISIN FR0000121667 / Valor 497537

Euronext - Euronext Paris (2026-11-03)
EUR 184.25-1.42%

EssilorLuxottica SA
UMushroom community rating:

star star star star star
4.00 5 votes No rating yet
NegativeNeutralPositive

About company

EssilorLuxottica SA is a global leader in the design, manufacture, and distribution of ophthalmic lenses, optical equipment, and prescription glasses and sunglasses. The company represents a merger of two industry giants, Essilor and Luxottica, combining their strengths in lens technology and eyewear brands. EssilorLuxottica's portfolio includes some of the most iconic names in the eyewear industry, such as Ray-Ban, Persol, and Oakley, alongside optical retailers like Salmoiraghi & Viganò and GrandVision. The company's history is rich, with roots tracing back to the 19th century, showcasing a long-standing tradition in the eyecare and eyewear sector. Through its comprehensive approach that covers every aspect of the eyewear experience—from innovation and design to production and distribution—EssilorLuxottica has established itself as a key player in the global market, dedicated to advancing the eyecare and eyewear industry for consumers around the world.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-41.9%1Y
5.74%3Y
-0.62%5Y

Performance

31.2%1Y
25.4%3Y
26.2%5Y

Volatility

Market cap

95238 M

Market cap (USD)

Daily traded volume (Shares)

774,672

Daily traded volume (Shares)

1 day high/low

235.2 / 231.9

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

5 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
4.68
Society:
starstarstarstarstar
3.84
Nature:
starstarstarstarstar
3.00
Sebastiano Ferrero
UK, 23 Oct 2026
star star star star star
Q3 2026 beat: revenue €7.49bn, +9% (+7.2% cc). Ray-Ban Meta wearables (+20%) and myopia-control lenses drive growth; vertical integration gives strong pricing power. Risks: premium valuation, cooling AI-glasses hype (Goldman cut to Neutral), FX.
Matteo Condorelli
Switzerland, 29 Sep 2026
star star star star star
Global leader with a strong competitive moat in eyewear. Vertical integration ensures financial stability, while tech partnerships drive innovation. Solid ESG profile, supported by initiatives for global eye care access.
Luca Fontana
Switzerland, 17 Mar 2026
star star star star star
Very solid share, in my opinion undervalued.

EQUITIES OF THE SAME SECTOR

AMN Healthcare Services Inc
AMN Healthcare Services Inc AMN Healthcare Services Inc Valor: 1269241
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.03%USD 45.30
FibroGen Inc
FibroGen Inc FibroGen Inc Valor: 25953994
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.36%USD 4.31
Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals Inc Syndax Pharmaceuticals Inc Valor: 24112479
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
9.08%USD 14.29
Evolent Health Inc
Evolent Health Inc Evolent Health Inc Valor: 28153126
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.37%USD 4.30
ALX Oncology Holdings Inc
ALX Oncology Holdings Inc ALX Oncology Holdings Inc Valor: 55754366
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.84%USD 1.29
Hims & Hers Health Inc
Hims & Hers Health Inc Hims & Hers Health Inc Valor: 59397181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.82%USD 25.70
Pacira BioSciences Inc
Pacira BioSciences Inc Pacira BioSciences Inc Valor: 12338490
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.03%USD 36.39
Ironwood Pharmaceuticals Inc
Ironwood Pharmaceuticals Inc Ironwood Pharmaceuticals Inc Valor: 10773079
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.16%USD 3.50
Addus HomeCare Corp
Addus HomeCare Corp Addus HomeCare Corp Valor: 10385048
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.64%USD 126.55
Arvinas Inc
Arvinas Inc Arvinas Inc Valor: 43526042
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.72%USD 7.09